Document is current
Any future updates will be listed below
-
Authors
Jones, Juan Camilo https://orcid.org/0009-0004-7202-4738
Costa, Marie
Sagaon-Teyssier, Luis https://orcid.org/0000-0001-7318-6596
Sow, Adbourahmane https://orcid.org/0000-0002-2840-0132
Beniguel, Lydie
Ben-Mechlia, Mohamed https://orcid.org/0009-0005-0918-0700
Assoumou, Lambert
Ghosn, Jade https://orcid.org/0000-0003-2914-959X
Costagliola, Dominique https://orcid.org/0000-0003-0765-0869
Manda, Victoria https://orcid.org/0009-0003-9328-9535
Protière, Christel https://orcid.org/0000-0002-5602-9617
Spire, Bruno https://orcid.org/0000-0002-3546-8020
Michels, David https://orcid.org/0009-0001-2230-0173
- License Information
-
More Information
Article History
Accepted: 3 April 2026
First Online: 28 April 2026
Declarations
:
: Dominique Costagliola reports personal fees from Pfizer (2022) for lectures outside the submitted work. All other authors declare no competing interests.
: The study obtained ethical approval from the ethics committee (CPP) Ile-de-France the ethics committee (number IV – 2016-AO1577) and the French Data Protection Authority (CNIL – DR-2017-118). It is registered on ClinicalTrials.gov (NCT03113123) and EudraCT (2016A0157744) ( ).
